Contact Us

News

  • WHO - GMP

    OSD Plant at Thane has been renewed with WHO GMP Certificate by CDSCO by Government of India

    2025-09-01 08:10:04

  • Eurasian GMP

    OSD plant at Thane has been approved by Eurasian authority for EAEU GMP for Tablet, Capsule, Liquid Oral and Ointment & Cream Facility

    2025-09-01 08:12:56

Quote

  • Company has Successfully started the opration at its Goa Plant for Oncology Products 

  • Launch of two products in our brand and for contract manufacturing Oseltamavir caps, 30mg, 45mg and 75 mg  And  Favipiravir 200 mg/400mg/800mg Tablet.

RND & ADL ATGAON THANE
  • Lok-Beta has Independent Research & Development facility approved by DSIR, Governments of India.
  • Development of new formulation in different segment under niche molecules category and the same will be commercialized in an upcoming six months.
  • Lok-Beta niche molecules such as Antiretroviral, Immunosuppressant, Urological, Antihypertensive, Anti diabetics and Anti Tuberculosis are aim is to provide /develop new formulation and application for the human well-being.
  •  Lok-Beta developed more than 25 Niche molecules and rigorously planning for develop @10 new products yearly